EE200200189A - Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt - Google Patents

Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Info

Publication number
EE200200189A
EE200200189A EEP200200189A EEP200200189A EE200200189A EE 200200189 A EE200200189 A EE 200200189A EE P200200189 A EEP200200189 A EE P200200189A EE P200200189 A EEP200200189 A EE P200200189A EE 200200189 A EE200200189 A EE 200200189A
Authority
EE
Estonia
Prior art keywords
leptin
vector
substance
determination
assay kit
Prior art date
Application number
EEP200200189A
Other languages
English (en)
Estonian (et)
Inventor
Rubinstein Menachem
Cohen Batya
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE200200189A publication Critical patent/EE200200189A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
EEP200200189A 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt EE200200189A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13231399A IL132313A0 (en) 1999-10-11 1999-10-11 Leptin assay
PCT/IL2000/000621 WO2001027319A2 (en) 1999-10-10 2000-10-05 Leptin assay based on detecting ang-2 expression

Publications (1)

Publication Number Publication Date
EE200200189A true EE200200189A (et) 2003-06-16

Family

ID=11073317

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200189A EE200200189A (et) 1999-10-11 2000-10-05 Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt

Country Status (24)

Country Link
US (1) US7247427B1 (no)
EP (1) EP1222467B1 (no)
JP (1) JP2003511057A (no)
KR (1) KR100863580B1 (no)
CN (1) CN1159585C (no)
AR (1) AR025995A1 (no)
AT (1) ATE322017T1 (no)
AU (1) AU778727B2 (no)
BR (1) BR0014626A (no)
CA (1) CA2386365A1 (no)
CY (1) CY1105025T1 (no)
DE (1) DE60027031T2 (no)
DK (1) DK1222467T3 (no)
EA (1) EA004709B1 (no)
EE (1) EE200200189A (no)
ES (1) ES2256045T3 (no)
HK (1) HK1048514B (no)
IL (2) IL132313A0 (no)
NO (1) NO20021604L (no)
PT (1) PT1222467E (no)
SI (1) SI1222467T1 (no)
UA (1) UA77153C2 (no)
WO (1) WO2001027319A2 (no)
ZA (1) ZA200202155B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2372364A1 (en) * 2010-03-31 2011-10-05 Medizinische Hochschule Hannover Biomarker for pulmonary hypertension
SI2661266T1 (sl) 2011-01-07 2021-01-29 Anji Pharma (Us) Llc Terapije, na osnovi kemosenzoričnih receptorskih ligandov
US9795792B2 (en) 2011-02-25 2017-10-24 Medtronic, Inc. Emergency mode switching for non-pacing modes
CN102221615A (zh) * 2011-03-31 2011-10-19 广州华灿医药科技有限公司 一种基于Angiogenin检测的双抗夹心ELISA方法
MX2014008190A (es) 2012-01-06 2015-02-04 Elcelyx Therapeutics Inc Composiciones de biguanida y métodos para tratar transtornos metabólicos.
MX2014008189A (es) 2012-01-06 2015-02-12 Elcelyx Therapeutics Inc Composiciones y metodos para tratar trastornos metabolicos.
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
AR091739A1 (es) 2012-07-11 2015-02-25 Elcelyx Therapeutics Inc Composiciones y metodos para reducir el riesgo cardiometabolico
CN102901823A (zh) * 2012-10-26 2013-01-30 安徽安科生物工程(集团)股份有限公司 瘦素检测试剂盒
JP6333855B2 (ja) 2013-01-05 2018-05-30 エルセリクス セラピューティクス インコーポレイテッド ビグアナイドを含む遅延放出組成物
CN104459105B (zh) * 2014-12-05 2016-03-09 重庆中元生物技术有限公司 一种检测lp的胶乳增强免疫比浊试剂盒及其制备方法
CN114940717B (zh) * 2022-06-30 2024-04-26 武汉海特生物制药股份有限公司 嵌合受体、32d瘦素敏感细胞株及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997040380A1 (en) * 1996-04-22 1997-10-30 Merck & Co., Inc. Leptin assay

Also Published As

Publication number Publication date
CN1378648A (zh) 2002-11-06
AU7814100A (en) 2001-04-23
DK1222467T3 (da) 2006-08-07
NO20021604D0 (no) 2002-04-04
KR20020048416A (ko) 2002-06-22
EP1222467A2 (en) 2002-07-17
WO2001027319A2 (en) 2001-04-19
EA004709B1 (ru) 2004-06-24
CY1105025T1 (el) 2010-03-03
EP1222467B1 (en) 2006-03-29
HK1048514A1 (en) 2003-04-04
IL149021A (en) 2007-12-03
DE60027031D1 (de) 2006-05-18
CA2386365A1 (en) 2001-04-19
KR100863580B1 (ko) 2008-10-15
ZA200202155B (en) 2003-05-28
SI1222467T1 (sl) 2006-06-30
IL149021A0 (en) 2002-11-10
PT1222467E (pt) 2006-06-30
NO20021604L (no) 2002-04-04
BR0014626A (pt) 2002-06-11
AR025995A1 (es) 2002-12-26
US7247427B1 (en) 2007-07-24
CN1159585C (zh) 2004-07-28
ES2256045T3 (es) 2006-07-16
UA77153C2 (en) 2006-11-15
JP2003511057A (ja) 2003-03-25
EA200200435A1 (ru) 2002-10-31
AU778727B2 (en) 2004-12-16
DE60027031T2 (de) 2006-08-24
HK1048514B (zh) 2004-12-31
IL132313A0 (en) 2001-03-19
ATE322017T1 (de) 2006-04-15
WO2001027319A3 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
ID25764A (id) Turunan-turunan ftalamida, atau garam-garamnya untuk insektisida agroholtikultura, dan metode penggunaannya
DE60130043D1 (de) Grundierungszusammensetzung und Beschichtungsverfahren
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
DE60103218D1 (de) Zugagangspunkt und Verfahren zur Verbindungssteuerung
DE60010923D1 (de) Vernetzbare kautschukzusammensetzung und vernetzter gegenstand
ID28787A (id) 2-fenilbenzimidazol tersubstitusi, pembuatannya dan penggunaannya
NL1014545A1 (nl) Oxim-derivaten en de toepassing daarvan als latente zuren.
AU2001252973A1 (en) Biosensor and related method
HUP0300371A3 (en) Tag library compounds, compositions, kits and methods of use
DE69928874D1 (de) Tonerzusammensetzung, Entwickler und Herstellungsverfahren
AU2002224079A1 (en) O/W emulsion composition and method of preparing the same
AU2002243391A1 (en) Beta-secretase transgenic organisms, anti-beta-secretase antibodies, and methods of use thereof
EE200200189A (et) Meetod leptiini või leptiinitaolise aine määramiseks, vektor ja analüüsikomplekt
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
AU2001274560A1 (en) Substrate activation kit and method of detecting dna or the like by using the same
EE200200282A (et) Keemilised meetodid ja vaheühendid
AU2001278011A1 (en) Bstp-ecg1 protein and related reagents and methods of use thereof
AU2002223743A1 (en) Means for detecting pathological transformation of the APP protein and their uses
DE60215326D1 (de) Mischsystem und -verfahren
EA200101260A1 (ru) Способ изменения физико-химических и/или биологических свойств вещества
AU5122500A (en) Detection of biological warfare agents
AU2001273052A1 (en) Antifungal compounds and methods of use
AU2001261676A1 (en) Method and reagent for the inhibition of erg
AU2001256892A1 (en) Reagent for detection of biomolecules, and use thereof
HK1044897A1 (zh) 心絞痛和/或不典型心絞痛的治療方法及其相關藥物組合物和藥劑盒